Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Product News

Product News

C096 77 Elektronika

Urine microscopy analyser

, 26 August 2020/in Product News /by 3wmedia

The UriSed mini is a professional semi-automated urine microscopy analyser producing whole fields of view microscopic images of urine sediment, and automatically classifying and counting urine sediment particles in the images. UriSed mini utilizes the traditional gold standard method while eliminating the most time-consuming and operator-dependent procedures in laboratories performing manual microscopy. In addition it can also serve as a backup instrument of automated sediment analysers. Main features include automatic identification of urine particles by the Auto Image Evaluation Module (AIEM); total measurement cycle of less than 1 minute; cost-effective operation without liquid reagents or calibrators. Easy to operate and requiring minimal training, the analyser is a highly effective tool in a wide range of medical and clinical settings.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C096_77-Elektronika.jpg 146 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:28:00Urine microscopy analyser
C056 SSI

ImmuLex™ S. pneumoniae Omni

, 26 August 2020/in Product News /by 3wmedia

The ImmuLex™ S. pneumoniae Omni is a rapid latex agglutination test for detection of S. pneumoniae.
It is a ready-to-use latex test for quick detection of 92 S. pneumoniae serotypes directly from a positive blood culture or from a pure culture. A positive reaction is visible to the naked eye within 5 seconds for blood culture and 10 seconds for pure culture.

Target group: Clinical microbiology laboratories, reference laboratories.

Features: Quick detection of all 92 serotypes of S. pneumoniae., positive reaction within 5 seconds (quickest reaction time on the market), time saving as there is no need for preliminary preparation of culture, the test can be made directly on a sample from the blood culture bottle, high sensitivity and specificity.

ImmuLex™ S. pneumoniae Omni kit contains a bottle of latex particles coated with pneumococcal antiserum raised in rabbits (0.0975% sodium azide as preservation), a positive and a negative control, and 25 reaction cards. ImmuLex™ S. pneumoniae Omni is provided in a 1 mL vial, which corresponds to approximately 75 tests.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C056_SSI.jpg 772 740 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:28:11ImmuLex™ S. pneumoniae Omni
C104 Euroimmun

Serological MERS-CoV tests

, 26 August 2020/in Product News /by 3wmedia

Serological tests have been developed for the detection of antibodies against MERS-CoV (Middle East respiratory syndrome coronavirus) in humans and in camels. MERS-CoV is an emerging pathogen which is responsible for an outbreak of severe acute respiratory illness predominantly in the Arabian Peninsula with a high number of fatalities. Camels are known hosts of the virus. The Anti-MERS-CoV indirect immunofluorescence test (IIFT) is an established, highly sensitive screening test for anti-MERS-CoV antibodies in human sera. The assay utilizes virus-infected cells as the antigenic substrate, with non-infected cells serving as a control. Positive samples yield a distinct fluorescence pattern on the infected cells. The EUROIMMUN Anti-MERS-CoV ELISA is the first commercially available anti-MERS-CoV ELISA. The assay microplates are coated with purified recombinant MERS-CoV spike protein S1 domain, which provides high sensitivity and specificity and reduces cross reactions with other human coronaviruses. Nevertheless, cross reactivity with other coronaviruses cannot be excluded with either the ELISA or the IIFT. For this reason, positive screening results should always be confirmed by a neutralization test, as stipulated by the World Health Organisation. The Anti-MERS-CoV IIFT Camel and the Anti-MERS-CoV ELISA Camel are based on the same test principles as the human tests and are suitable for determining antibody levels in camels. The human and camel serological assays have been used in numerous published studies on MERS-CoV infection mechanisms. Notably, it was found that there are no significant levels of anti-MERS-CoV antibodies in human subjects from Saudi Arabia. This implies that the virus has not been circulating in humans for long and that the majority of the population remains susceptible to infection. Studies in dromedary camels, on the other hand, have revealed high seropositivity in animals from the Arab region and Eastern Africa, even in samples that are decades old. Thus, MERS-CoV appears to have been circulating widely in dromedaries for some time. Since the virus can sporadically pass from camels to humans, dromedaries represent a significant risk factor for infection in people.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C104_Euroimmun.jpg 113 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:27:55Serological MERS-CoV tests
C082 Analyticon

Recombinant Prothrombin Time (PT) reagent

, 26 August 2020/in Product News /by 3wmedia

The liquid-stable reagent from Analyticon is produced by utilizing the most advanced technology in PT testing as it is based on a recombinant human tissue factor (TF). It is used for the quantitative determination of Prothrombin Time (PT) in human citrated plasma and the evaluation of extrinsic coagulation factor assays II, V, VII and X. The sensitivity of PT tests towards vitamin K-dependent clotting factors strongly depends upon the source and type of the TF. Since the recombinant TF in the PT reagent from Analyticon does not contain any contaminating coagulation factors it is particularly appropriate for extrinsic pathway factor assays and for monitoring oral anticoagulant therapy (OAT). The recombinant PT is a liquid-stable reagent with excellent open and closed vial stability (> 12 months at 2-8°). The instrument-based ISI of approximately 1.0 has been calibrated against an International Reference Preparation for accurate INR results. An ISI values of 1.0 or below demonstrates the sensitivity and responsiveness towards oral anticoagulants.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C082_Analyticon.jpg 94 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:28:05Recombinant Prothrombin Time (PT) reagent
C040 WestMedica

Digital system for sperm analysis

, 26 August 2020/in Product News /by 3wmedia

Vision Sperm is an integrated system for conducting sperm quality analysis and managing microscopy samples, patient data and analysis results. The system makes it possible to store and examine digital sperm samples and analysis results. Accurate and objective analysis supported by report documentation and specialized soft ware provides greater assurance in analysis results. Working with the Vision Sperm system does not lead to fatigue and red eyes and reduces the load on neck and hand muscles that accompanies routine microscopy. By working with the system, doctors and laboratory professionals improve their expertise every day, thanks to the use of atlas, review of images and comments as well as discussion with colleagues and experts. Information exchange makes up for a lack of specialists. Accurate diagnosis and an appropriate strategy for further examination will ensure correct treatment of the patient.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C040_WestMedica.jpg 117 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:28:14Digital system for sperm analysis
C114 Greiner image1 01

Rapid detection of toxigenic C. difficile

, 26 August 2020/in Product News /by 3wmedia

The Genspeed C.diff OneStep test identifies toxigenic C. difficile by combining detection of Glutamate Dehydrogenase (GDH), Toxin A, Toxin B and binary toxin in a single, molecular diagnostic test. The complete analysis including the detection on the Genspeed R2 analyser takes under 100 min. The new test addresses one of the most serious threats to healthcare systems worldwide, Clostridium difficile infection (CDI), which is believed to be the most common healthcareassociated infection. The disease is causing antibiotic-associated diarrhea (AAD) that may lead to pseudomembranous colitis and even to death. In a 2013 pub-lished report, the Center for Disease Control (CDC) in the USA categorized C. difficile infections as “Threat Level Urgent”, the highest level available. The Genspeed C.diff OneStep test features a simple, one-step molecular diagnostic test, avoiding the currently used sequential 2-step diagnostic test procedures which combine different test systems and assay principles for GDH and the C. difficile toxins. The rapid test provides conclusive results without the need for confirmatory re-testing and enables inter-laboratory comparisons of test results. Ready-touse reagents and automated dispensing minimize the number of manual process steps within the workflow. The Genspeed R2 analyser represents a reliable solution for customers interested in fast and accurate results. The virtually service-free system is simple to operate and is available at an attractive cost-benefit ratio. Genspeed products are currently available for sale in the EU and EFTA countries only. Availability in other countries outside the US is on request.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C114_Greiner_image1_01.jpg 599 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:27:48Rapid detection of toxigenic C. difficile
C094 Awareness

Autoimmune and more

, 26 August 2020/in Product News /by 3wmedia

Awareness Technology, Inc. announces expansion of its line of ReQuest(TM) microwell based ELISA kits.  Products include  ANA, ENA, dsDNA, SSA, SSB, RNP,  SmRNP, Scl 70  and AntiJo1 in addition to syphilis, h pylori and complete panels for MMR, TORCH and  EBV.  The 32- year old company also supplies kits for Vitamin D and a full line of specific allergens and antigens causing hypersensitivity pneumonitis. All products are manufactured in Florida, under  US FDA and ISO 13485. Autoimmune kits are cleared by US FDA, Canadian Health, and have CE mark.  To learn more about the full line of reagents, as well as both semi and  fully automatic instrument systems, visit Hall 2 booth A-15 at MEDICA or browse, www.awaretech.com. Branch offices are available in USA, Europe, and Asia.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C094_Awareness.jpg 150 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:27:58Autoimmune and more
C061 EKF

Centrifuge

, 26 August 2020/in Product News /by 3wmedia

The new PlasmaPrep-12 centrifuge is suitable for use in both the hospital and laboratory. It is designed for STAT serum/plasma separation and is perfect for coagulation studies. Enabling fast blood separation and easy to use, it is controlled by a microprocessor with four pre-programmed spin times. These include the Platelet Poor Plasma mode providing serum or plasma separations in three minutes and the Platelet Rich Plasma mode providing platelet rich plasma in just 30 seconds.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C061_EKF.jpg 150 120 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:28:08Centrifuge
C116 vedalab 01

New Generation Rapid Test Reader

, 26 August 2020/in Product News /by 3wmedia

The VEDALAB Easy Reader+ is a rapid test quantitative reader including the most advanced and up-to-date technology for in vitro diagnostic use. Key features of Easy Reader+ include flexible user interface offering easy mode and advanced mode; integrated printer and touch screen; optimal communication with USB A, USB B, Ethernet and RS232 interfaces. Data storage of the last 1,000 results with images is provided. This multilingual, battery-operated affordable instrument is currently usable for 34 parameters with more to come.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C116_vedalab_01.jpg 966 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:36:57New Generation Rapid Test Reader
C101 Stago embolie p

D-Dimer test meets new CLSI H59-A standards for exclusion of pulmonary embolism

, 26 August 2020/in Product News /by 3wmedia

Stago has received approval from the US Food and Drug Administration (FDA) for the STA-Liatest D-Di reagent for the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit. FDA requirements for D-dimer assays for exclusion are now based on the new and more restrictive standards established and published by the Clinical Laboratory Standards Institute (CLSI, H59-A). Stago’s rapid, automated and highly sensitive D-Dimer is the first test to comply with these new requirements. In order to comply with the new CLSI guidelines, the company performed a 2-years international prospective study similar to clinical studies performed in the pharmaceutical field (9 sites, 5 countries, more than 1100 patients, including evaluation of clinical pretest probability, imaging and 3 months of follow-up), a first in the field of hemostasis diagnostics. As its coordinator Prof. Gilles Pernod (Grenoble University Hospital, France) pointed out: “As well as providing the results required to validate this test for the exclusion of PE, this study brought to light some significant evolutions in clinical practice and shifts in prevalence. In fact, these findings will be presented in some interesting upcoming publications”. This study also confirmed the excellent diagnostic performance of the STA-Liatest D-Di assay, with a very high negative predictive value (NPV) for the exclusion of PE, far exceeding FDA requirements (>99.7% versus 97%), and excellent sensitivity (>97% versus 95%). The second part of this international clinical study, concerning deep vein thrombosis (DVT), is underway and due to be completed in the next few months.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C101_Stago_embolie-p.jpg 150 85 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:522021-01-08 11:28:00D-Dimer test meets new CLSI H59-A standards for exclusion of pulmonary embolism
Page 109 of 149«‹107108109110111›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
13 November 2025

New Chromsystems Product for Antiepileptic Drugs Testing

11 November 2025

Trusted analytical solutions for reliable results

10 November 2025

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription